Randomised controlled trial of topical corticosteroid and home-based narrowband UVB for active and limited vitiligo – results of the HI-Light Vitiligo trial Short title: Home-based narrowband UVB and topical steroid for vitiligo

through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/bjd.19592 This article is protected by copyright. All rights reserved PROFESSOR KIM S THOMAS (Orcid ID : 0000-0001-7785-7465) DR JONATHAN BATCHELOR (Orcid ID : 0000-0002-7728-2021) DR JOANNE RACHEL CHALMERS (Orcid ID : 0000-0002-2281-7367) MR ANDY ROGERS (Orcid ID : 0000-0003-4734-9528) DR TRACEY H SACH (Orcid ID : 0000-0002-8098-9220) DR M. SANTER (Orcid ID : 0000-0001-7264-5260) DR JOHN R INGRAM (Orcid ID : 0000-0002-5257-1142) PROFESSOR NICK J LEVELL (Orcid ID : 0000-0003-3393-8305)

[1]  T. Braunberger,et al.  International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation , 2018, The British journal of dermatology.

[2]  H. Williams,et al.  Home interventions and light therapy for the treatment of vitiligo (HI-Light Vitiligo Trial): study protocol for a randomised controlled trial , 2018, BMJ Open.

[3]  K. Thomas,et al.  Views and experiences of seeking information and help for vitiligo: a qualitative study of written accounts , 2018, BMJ Open.

[4]  R. Schwartz,et al.  Vitiligo and depression: a systematic review and meta‐analysis of observational studies , 2017, The British journal of dermatology.

[5]  R. Sarkany,et al.  Are very high cumulative doses of narrowband UVB safe in vitiligo? , 2017, Photodermatology, photoimmunology & photomedicine.

[6]  J. Bae,et al.  Phototherapy for Vitiligo: A Systematic Review and Meta-analysis , 2017, JAMA dermatology.

[7]  T. Mohammad,et al.  The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo , 2017, Journal of the American Academy of Dermatology.

[8]  Yunfei Cai,et al.  The Prevalence of Vitiligo: A Meta-Analysis , 2016, PloS one.

[9]  Lena Osterhagen,et al.  Multiple Imputation For Nonresponse In Surveys , 2016 .

[10]  A. Montgomery,et al.  Validation of the Vitiligo noticeability scale: a patient-reported outcome measure of Vitiligo treatment success , 2015, Trials.

[11]  John E. Harris,et al.  Vitiligo is not a cosmetic disease. , 2015, Journal of the American Academy of Dermatology.

[12]  T. Jouary,et al.  Living with vitiligo: results from a national survey indicate differences between skin phototypes , 2015, The British journal of dermatology.

[13]  M. Picardo,et al.  Developing core outcome set for vitiligo clinical trials: international e‐Delphi consensus , 2015, Pigment cell & melanoma research.

[14]  Steven Thng Tien Guan,et al.  Randomized, parallel group trial comparing home-based phototherapy with institution-based 308 excimer lamp for the treatment of focal vitiligo vulgaris. , 2015, Journal of the American Academy of Dermatology.

[15]  K. Thomas,et al.  Survey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligo , 2014, BMC Dermatology.

[16]  H. Williams,et al.  Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home Intervention of Light therapy) , 2014, Trials.

[17]  M. Picardo,et al.  Guidelines for the management of vitiligo: the European Dermatology Forum consensus , 2013, The British journal of dermatology.

[18]  K. Thomas,et al.  Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials , 2012, The British journal of dermatology.

[19]  Z. Hallaji,et al.  Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy , 2012, Photodermatology, photoimmunology & photomedicine.

[20]  R. Spritz.  The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma , 2010, Genome Medicine.

[21]  A. Bewley,et al.  Vitiligo is more than skin deep: a survey of members of the Vitiligo Society , 2010, Clinical and experimental dermatology.

[22]  M J Watts,et al.  Guideline for the diagnosis and management of vitiligo , 2008, The British journal of dermatology.

[23]  I. L. Le Poole,et al.  HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. , 2008, The Journal of investigative dermatology.

[24]  M. Zeegers,et al.  Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? , 2008, Experimental dermatology.

[25]  V. Sehgal,et al.  Vitiligo: compendium of clinico-epidemiological features. , 2007, Indian journal of dermatology, venereology and leprology.

[26]  J. Hawk,et al.  Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy. , 2007, Archives of dermatology.

[27]  M. Picardo,et al.  A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. , 2006, Pigment cell research.

[28]  B. Diffey,et al.  An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report , 2004, The British journal of dermatology.

[29]  P. Das,et al.  Autoimmune aspects of depigmentation in vitiligo. , 2004, The journal of investigative dermatology. Symposium proceedings.

[30]  R. Little,et al.  Inference for the Complier-Average Causal Effect From Longitudinal Data Subject to Noncompliance and Missing Data, With Application to a Job Training Assessment for the Unemployed , 2001 .

[31]  A. Taïeb,et al.  Intrinsic and extrinsic pathomechanisms in vitiligo. , 2000, Pigment cell research.

[32]  W. Westerhof,et al.  Review of the etiopathomechanism of vitiligo: A convergence theory , 1993, Experimental dermatology.

[33]  J. Nordlund,et al.  Psychosocial effect of vitiligo: a comparison of vitiligo patients with "normal" control subjects, with psoriasis patients, and with patients with other pigmentary disorders. , 1986, Journal of the American Academy of Dermatology.

[34]  Malkit Singh,et al.  Clinical Pattern of Vitiligo in Libya , 1985, International journal of dermatology.

[35]  D. Rao,et al.  Studies on vitiligo I. Epidemiological profile in Calcutta, India , 1985, Genetic epidemiology.

[36]  J. Nordlund,et al.  Psychological reaction to chronic skin disorders: a study of patients with vitiligo. , 1979, General Hospital Psychiatry.

[37]  J. Nordlund,et al.  Personal responses of patients to vitiligo: the importance of the patient-physician interaction. , 1978, Archives of dermatology.